{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:07:02Z","timestamp":1790287622144,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009820","name":"Assistance publique-H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0051"],"award-info":[{"award-number":["ANR-11-LABX-0051"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["2018-A0040710370"],"award-info":[{"award-number":["2018-A0040710370"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["2020-A0080711465"],"award-info":[{"award-number":["2020-A0080711465"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["2020- A0070710961"],"award-info":[{"award-number":["2020- A0070710961"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-IDEX-0005-02"],"award-info":[{"award-number":["ANR-11-IDEX-0005-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010190","name":"Grand Equipement National De Calcul Intensif","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tracli.2021.04.007","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T19:19:48Z","timestamp":1619119188000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Floch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.04.007_bib0375","series-title":"The Blood Group Antigen FactsBook","author":"Reid","year":"2012"},{"key":"10.1016\/j.tracli.2021.04.007_bib0380","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bmj.1.4868.962","article-title":"Haemolytic disease of the newborn caused by a new Rh antibody, anti-Cx","volume":"1","author":"Stratton","year":"1954","journal-title":"Br Med J"},{"key":"10.1016\/j.tracli.2021.04.007_bib0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1537-2995.1971.tb04380.x","article-title":"Hemolytic disease of the newborn due to anti-EW. A fourth example of the Rh antigen, EW","volume":"11","author":"Grobel","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0390","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000075147","article-title":"Fetal hemolytic disease due to anti-Rh17 alloimmunization","volume":"19","author":"Hirose","year":"2004","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.tracli.2021.04.007_bib0395","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000503012","article-title":"The outcome of hemolytic disease of the fetus and newborn caused by anti-Rh17 antibody: analysis of three cases and review of the literature","volume":"47","author":"Dajak","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.04.007_bib0400","first-page":"225","article-title":"Rh18 and hrS blood groups and antibodies","volume":"66","author":"Moores","year":"1994","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0405","first-page":"P250","article-title":"A review of the clinical significance of anti-RH19 and anti-RH34 antibodies detected in South African patients","volume":"91","author":"Smart","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1537-2995.1982.22182154231.x","article-title":"Hemolytic disease of the newborn due to anti-VS","volume":"22","author":"Behzad","year":"1982","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0415","first-page":"43S","article-title":"Incidence of hemolytic disease of the newborn due to anti-Dw","volume":"37","author":"Spruell","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0420","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/trf.12937","article-title":"Short duplication within the RHCE gene associated with an in cis deleted RHD causing a Rhnull amorph phenotype in an immunized pregnant woman with anti-Rh29","volume":"55","author":"Silvy","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0425","first-page":"43","article-title":"Severe haemolytic disease in an infant born to an Rh(null) proposita","volume":"63","author":"Lubenko","year":"1992","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0430","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-2007-994762","article-title":"Severe hemolytic disease of the newborn caused by anti-Gonzales antibody","volume":"10","author":"Leschek","year":"1993","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0435","first-page":"225","article-title":"Transfusion considerations concerning patients with anti-hrB and confounding co-morbid conditions: pregnancy and coagulopathy","volume":"9","author":"Savage","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2021.04.007_bib0440","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1537-2995.1991.31191096188.x","article-title":"Hemolytic disease of the newborn caused by anti-Rh32 and demonstration that RN encodes rhi (Ce, Rh7)","volume":"31","author":"Issitt","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0445","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1423-0410.2009.01277.x","article-title":"The low prevalence Rh antigen Be(a) (Rh36) is associated with RHCE*ce 662C>G in exon 5, which is predicted to encode Rhce 221Arg","volume":"98","author":"Hue-Roye","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0450","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1423-0410.1978.tb02469.x","article-title":"The Rh antigen Evans","volume":"34","author":"Contreras","year":"1978","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0455","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2257.1983.tb01368.x","article-title":"The Rh antigen Tar (Rh40) causing haemolytic disease of the newborn","volume":"5","author":"Levene","year":"1983","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0460","first-page":"631","article-title":"Anti-Ces: a previously undescribed Rh antibody","volume":"20","author":"Moulds","year":"1980","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0465","first-page":"410","article-title":"Riv: a new low incidence Rh antigen","volume":"23","author":"Delehanty","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0470","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1537-2995.1989.29990070185.x","article-title":"A serologic study of red cells and sera from 18 Rh:32-46 (RN\/RN) persons","volume":"29","author":"Le Pennec","year":"1989","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0475","first-page":"39","article-title":"A low-incidence red cell antigen JAL associated with two unusual Rh gene complexes","volume":"59","author":"Lomas","year":"1990","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0480","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-3148.1993.tb00102.x","article-title":"STEM, a new low-frequency Rh antigen associated with the e-variant phenotypes hrS\u2013 (Rh: \u201318\u201319) and hrB\u2013 (Rh: \u201331, \u201334)","volume":"3","author":"Marais","year":"1993","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.04.007_bib0485","first-page":"410","article-title":"A new high frequency Rh red cell antigen associated with the Rh antigen Cx","volume":"23","author":"Mougey","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0490","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tracli.2017.06.208","article-title":"Anticorps anti-priv\u00e9 dans le syst\u00e8me RH et maladie h\u00e9molytique du nouveau-n\u00e9\u00a0?\u00a0: \u00e0 propos de 2 cas","volume":"24","author":"Toly-Ndour","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0495","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1537-2995.1994.34694295063.x","article-title":"A \u201cnew\u201d low-incidence red cell antigen, LOCR, associated with altered expression of Rh antigens","volume":"34","author":"Coghlan","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0500","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1537-2995.2010.02764.x","article-title":"RHCE*ceCFencodes partial c and partial e but not CELO, an antigen antithetical to Crawford","volume":"51","author":"Hipsky","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1983.23283172867.x","article-title":"Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother","volume":"23","author":"Lacey","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0510","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-3148.1997.d01-32.x","article-title":"DBT: a partial D phenotype associated with the low-incidence antigen Rh32","volume":"7","author":"Wallace","year":"1997","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.04.007_bib0515","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1537-2995.1996.36596282599.x","article-title":"Hemolytic disease of the newborn caused by alloanti-D from an R0Har r Rh:33 mother","volume":"36","author":"Hazenberg","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2257.1991.tb00278.x","article-title":"\"Partial D\u201d women with anti-D alloimmunization in pregnancy","volume":"13","author":"Mayne","year":"1991","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0525","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1046\/j.1537-2995.1991.31892023512.x","article-title":"Partial D antigens disclosed by a monoclonal anti-D in Japanese blood donors","volume":"31","author":"Okubo","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0530","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1447-0756.2010.01364.x","article-title":"Rare case of hemolytic death of the newborn due to anti-hr0 and anti-e","volume":"37","author":"Gong","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.tracli.2021.04.007_bib0535","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/trf.14944","article-title":"Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31)","volume":"58","author":"Turley","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0540","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000446816","article-title":"Anti-D antibodies in pregnant D variant antigen carriers initially typed as RhD","volume":"43","author":"Lukacevic Krstic","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.04.007_bib0545","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/trf.14156","article-title":"Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn","volume":"57","author":"Quantock","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0550","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/trf.14638","article-title":"Molecular characterization of three novel RHD alleles in Brazilians","volume":"58","author":"Aparecida de Paula Vendrame","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0555","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1537-2995.2009.02573.x","article-title":"DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications","volume":"50","author":"Westhoff","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0560","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1537-2995.1996.36696269518.x","article-title":"Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype","volume":"36","author":"Beckers","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0565","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1537-2995.2011.03538.x","article-title":"Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype","volume":"52","author":"Gardener","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0570","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21307\/immunohematology-2019-009","article-title":"Two cases of the variant RHD*DAU5 allele associated with maternal alloanti-D","volume":"33","author":"Duncan","year":"2017","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2021.04.007_bib0575","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1537-2995.2012.03743.x","article-title":"RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBIallele in people of African descent","volume":"53","author":"Roussel","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0580","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000370217","article-title":"Prospective evaluation of a transfusion policy of RhD-positive red blood cells into DEL patients in China","volume":"42","author":"Xu","year":"2015","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.04.007_bib0585","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/tme.12211","article-title":"Anti-D alloimmunisation in pregnant women with DEL phenotype in China","volume":"25","author":"Wang","year":"2015","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.04.007_bib0590","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1537-2995.2004.04003.x","article-title":"A new hybrid RHCE gene (CeNR) is responsible for expression of a novel antigen","volume":"44","author":"Westhoff","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0595","first-page":"204","article-title":"A pregnant woman with antibodies against a high-frequency RH antigen","volume":"103","author":"de Haas","year":"2012","journal-title":"Vox Sang;"},{"key":"10.1016\/j.tracli.2021.04.007_bib0600","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1423-0410.2011.01519.x","article-title":"Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system","volume":"102","author":"Hipsky","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-2977(69)80066-0","article-title":"[The gene complex DIV (C)-]","volume":"12","author":"Salmon","year":"1969","journal-title":"Rev Fr Transfus"},{"key":"10.1016\/j.tracli.2021.04.007_bib0610","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0035-2977(69)80065-9","article-title":"[A new example of rhesus genotype cD--cD-]","volume":"12","author":"Delmas-Marsalet","year":"1969","journal-title":"Rev Fr Transfus"},{"key":"10.1016\/j.tracli.2021.04.007_bib0615","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1537-2995.1996.36296181934.x","article-title":"Deletion of E and e antigens in a pregnant woman","volume":"36","author":"Cotorruelo","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0620","first-page":"398","article-title":"An Rh gene complex Dc-","volume":"5","author":"Tate","year":"1960","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0625","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0002-9378(16)36267-6","article-title":"Severe erythroblastosis in a primigravida associated with absence of Rh chromosomes","volume":"82","author":"De Torregrosa","year":"1961","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0630","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1537-2995.2004.04082.x","article-title":"Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17","volume":"44","author":"Denomme","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0635","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-3148.2009.00946.x","article-title":"Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17","volume":"20","author":"Li","year":"2010","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.04.007_bib0640","first-page":"143","article-title":"Anti-Rh 29 in a primigravida with rhesus null syndrome resulting in haemolytic disease of the newborn","volume":"53","author":"Gabra","year":"1987","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0645","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2002-01-0229","article-title":"Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety","volume":"100","author":"Noizat-Pirenne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.04.007_bib0650","doi-asserted-by":"crossref","DOI":"10.21037\/aob-20-84","article-title":"Molecular genetics of the RH blood group system: alleles and antibodies","author":"Floch","year":"2021","journal-title":"Ann Blood"},{"key":"10.1016\/j.tracli.2021.04.007_bib0655","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1537-2995.1997.37111298088040.x","article-title":"Involvement of Gly96 in the formation of the Rh26 epitope","volume":"37","author":"Faas","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0660","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1182\/blood.V87.11.4853.bloodjournal87114853","article-title":"Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC\/e in RN phenotypes","volume":"87","author":"Rouillac","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.04.007_bib0665","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/trf.14633","article-title":"High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients","volume":"58","author":"Floch","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0670","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1111\/trf.13225","article-title":"RHCE*ceAG (254C>G, Ala85Gly) is prevalent in blacks, encodes a partial ce-phenotype, and is associated with discordant RHD zygosity","volume":"55","author":"Westhoff","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0675","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000490858","article-title":"Genotyping in sickle cell disease patients: the French Strategy","volume":"45","author":"Floch","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.04.007_bib0680","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/trf.12271","article-title":"RHCE*ceMO is frequently in cis to RHD*DAU0 and encodes a hr(S) -, hr(B) -, RH:-61 phenotype in black persons: clinical significance","volume":"53","author":"Westhoff","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.04.007_bib0685","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.02802.x","article-title":"Two new alleles of the RHCE gene in Black individuals: the RHce allele ceMO and the RHcE allele cEMI","volume":"113","author":"Noizat-Pirenne","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0690","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000366176","article-title":"The Rhesus Site","volume":"41","author":"Wagner","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.04.007_bib0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmrv.2021.04.002","article-title":"A review of the literature organized in a new database: RHeference","author":"Floch","year":"2021","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2021.04.007_bib0700","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.transci.2019.03.023","article-title":"Reconsidering RhD positive blood transfusion for Asia type DEL patients","volume":"58","author":"Kim","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2021.04.007_bib0705","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/bloodadvances.2016001867","article-title":"a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project","volume":"1","author":"M\u00f6ller","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2021.04.007_bib0710","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0037-1963(00)90044-1","article-title":"Summary of the clinical significance of blood group alloantibodies","volume":"37","author":"Reid","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0715","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2020-021","article-title":"Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems","volume":"35","author":"Thornton","year":"2019","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2021.04.007_bib0720","series-title":"Rh and RHAG Blood Group Systems. Human Blood Groups","author":"Daniels","year":"2013"},{"key":"10.1016\/j.tracli.2021.04.007_bib0725","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1423-0410.2008.01135.x","article-title":"Alloanti-c in a c-positive, JAL-positive patient","volume":"96","author":"Ong","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0730","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/MPH.0000000000000241","article-title":"Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease","volume":"37","author":"Ipe","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tracli.2021.04.007_bib0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/vox.12717","article-title":"International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings","volume":"114","author":"Storry","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.04.007_bib0740","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/trf.16301","article-title":"Insights into anti-D formation in carriers of RhD variants through studies of 3D intraprotein interactions","volume":"61","author":"Floch","year":"2021","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:22:22Z","timestamp":1777609342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1246782021000689"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.04.007","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}